Tokyo, March 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060788) titled 'Prognostic Significance of Postoperative and Post-Adjuvant Circulating Tumor DNA in Resected Colon Cancer: A Systematic Review and Meta-Analysis' on March 1.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Asakayama General Hospital
Condition:
Condition - Colon Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Prognostic Accuracy of ctDNA in the Postoperative and Post-Adjuvant Chemotherapy Settings of Colon Cancer
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - The eligibility criteria were defined as follows. Studies were included if they met all of the following conditions: (1) patients with colon cancer who underwent curative-intent surgery; (2) postoperative ctDNA testing performed using plasma samples only; and (3) an observational (prospective or retrospective cohort) or randomized controlled trial design.
Key exclusion criteria - Studies were excluded if: (1) they reported updated results from previously published cohorts without providing independent data; (2) outcome data were not extractable or were insufficient to estimate effect sizes; or (3) the primary focus was cost-effectiveness analysis rather than prognostic outcomes.
Target Size - 1000
Recruitment Status:
Recruitment status - Suspended
Date of protocol fixation - 2026 Year 01 Month 01 Day
Date of IRB - 2026 Year 03 Month 01 Day
Anticipated trial start date - 2026 Year 03 Month 01 Day
Last follow-up date - 2027 Year 03 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069484
Disclaimer: Curated by HT Syndication.
